✦ LIBER ✦

Observer error in the characterization of hepatic lesions in patients with neoplastic liver disease

✍ Scribed by Neill A Iscoe; John D McKee; Anna Marie Arenson; John P Szalai

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 249 KB
Volume: 16
Category: Article
ISSN: 0091-2751
DOI: 10.1002/jcu.1870160808

No coin nor oath required. For personal study only.

✦ Synopsis

Sixteen patients with known neoplastic liver disease underwent 20 ultra- sound examinations by two separate teams to determine the level of agreement in the measurement of lesion size and sonographic characteristics. The intraclass correlation coefficient for the observations on lesion size was r = 0.97 (95% lower confidence limit r = 0.96). We conclude that sonographic estimation of the size of neoplastic liver lesions in highly reproducible and that the measurements obtained may be safely incorporated into the criteria of response for cancer clinical trials.

📜 SIMILAR VOLUMES

Assessment of hepatic vitamin E status i

Assessment of hepatic vitamin E status in adult patients with liver disease

✍ A Nagita; M Ando 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

No published reports compare hepatic alpha-tocopherol (adjusted for hepatic lipid content) with indicators of blood alpha-tocopherol in adult patients with various liver diseases. alpha-Tocopherol was simultaneously measured in liver biopsy tissues and blood from 66 subjects (9 comparison patients h

Detection of hepatic oxidative DNA damag

Detection of hepatic oxidative DNA damage in patients with hepatoblastoma and children with non-neoplastic disease

✍ Ikeda, Hitoshi ;Hirato, Junko ;Suzuki, Norio ;Kuroiwa, Minoru ;Maruyama, Kenichi 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB

## Abstract ## Background The authors have revealed a significant association between hepatoblastoma and low birth weight. This study was done to explore the evidence that liver cells were oxidatively damaged, based on the hypothesis that oxidative damage to DNA is involved in the development of h

Safety and immunogenicity of hepatitis A

Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

✍ Emmet B. Keeffe; Sten Iwarson; Brian J. McMahon; Karen L. Lindsay; Raymond S. Ko 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

Acute hepatitis A superimposed on chronic liver disease (CLD) has been associated with severe or fulminant hepatitis. An open, multicenter study was performed to compare the safety and immunogenicity of an inactivated hepatitis A vaccine in patients with CLD with that in healthy subjects. A secondar

Clinical significance of concomitant hep

Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease

✍ Tse-Ling Fong; Gary C. Kanel; Andrew Conrad; Boontar Valinluck; Francine Charbon 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB 👁 2 views

The significance of antibodies to hepatitis C virus in patients with chronic alcoholic liver disease is unclear. Prior studies have utilized the first-generation enzyme-linked immunosorbent assay, which is limited by problems with sensitivity and specificity. Hepatitis C virus infection in 137 pati

The risk of surgery in patients with liv

The risk of surgery in patients with liver disease

✍ Lawrence S. Friedman 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Because of the multiple functions of the liver-synthesis of most serum proteins, metabolism of nutrients and drugs, excretion and detoxification of endogenous toxins and exogenous agents, and filtering of portal venous blood-assessing the risk of surgery in patients with liver disease is a challengi

Hepatic encephalopathy as a predictor of

Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease

✍ Charmaine A. Stewart; Michael Malinchoc; W. Ray Kim; Patrick S. Kamath 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

Hepatic encephalopathy (HE) is an important component of hepatic decompensation, which reduces survival in patients with cirrhosis. The Model for End-Stage Liver Disease (MELD) score has been used to predict survival of patients with cirrhosis. The aims of this study were to determine whether HE is